Skip to main content
. 2021 Dec 1;12:732698. doi: 10.3389/fphar.2021.732698

TABLE 4.

The analysis outcomes of FBG 04 in the high-dosage group in study 2.

Critical values (mmol/L) Reached (n) HbA1c012>0% (n) Percentage (%)
0.1 46 41 89.1
0.2 43 38 88.4
0.3 37 34 91.9 a
0.4 34 33 97.1 a
0.5 32 31 96.9 a
0.6 38 29 96.7 a
0.7 26 25 96.2 a
0.8 24 23 95.8 a
0.9 20 19 95.0
1.0 18 17 94.4
1.1 15 14 93.3
a

Significant at p < 0.05.0.3 mmol/L was the first percentage more than 85% at p < 0.05.